Bifogade filer
Notice to convene - Extraordinary general meeting 17 February 2020 - Veloxis Pharmaceuticals
Kurs
0,00%
Kalender
| Est. tid* | ||
| 2020-11-10 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-12 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-13 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-29 | - | Årsstämma |
| 2020-03-31 | - | Bokslutskommuniké 2019 |
| 2019-11-12 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-08 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-06 | - | Kvartalsrapport 2019-Q1 |
| 2019-04-04 | - | X-dag ordinarie utdelning VELO 0.00 DKK |
| 2019-04-03 | - | Årsstämma |
| 2019-02-27 | - | Bokslutskommuniké 2018 |
| 2018-11-14 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-13 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-14 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-16 | - | X-dag ordinarie utdelning VELO 0.00 DKK |
| 2018-04-13 | - | Årsstämma |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-11-14 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-16 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-16 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-10 | - | X-dag ordinarie utdelning VELO 0.00 DKK |
| 2017-04-07 | - | Årsstämma |
| 2017-02-28 | - | Bokslutskommuniké 2016 |
| 2016-11-16 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-24 | - | Kvartalsrapport 2016-Q2 |
| 2016-07-26 | - | Extra Bolagsstämma 2016 |
| 2016-05-18 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-07 | - | X-dag ordinarie utdelning VELO 0.00 DKK |
| 2016-04-06 | - | Årsstämma |
| 2016-03-09 | - | Bokslutskommuniké 2015 |
| 2015-11-11 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-20 | - | Kvartalsrapport 2015-Q1 |
| 2015-03-27 | - | X-dag ordinarie utdelning VELO 0.00 DKK |
| 2015-03-26 | - | Årsstämma |
| 2015-03-03 | - | Bokslutskommuniké 2014 |
| 2014-04-10 | - | X-dag ordinarie utdelning VELO 0.00 DKK |
| 2013-04-18 | - | X-dag ordinarie utdelning VELO 0.00 DKK |
| 2013-04-17 | - | Årsstämma |
| 2012-04-19 | - | X-dag ordinarie utdelning VELO 0.00 DKK |
| 2011-04-13 | - | X-dag ordinarie utdelning |
| 2010-04-22 | - | X-dag ordinarie utdelning |
Beskrivning
| Land | Danmark |
|---|---|
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Company Announcement no. 11/2020
To: NASDAQ Copenhagen A/S
Copenhagen, Denmark, 24 January 2020
Notice to Convene Extraordinary General Meeting
Upon request from Asahi Kasei Pharma Denmark A/S, the board of directors of Veloxis Pharmaceuticals A/S, CVR no. 26 52 77 67 (the "Company"), hereby convenes an extraordinary general meeting in the Company to be held on
Monday 17 February 2020 at 12:00 p.m. CET
at the offices of Plesner Law Firm, Amerika Plads 37, 2100 Copenhagen, Denmark.
Shareholders who have accepted the voluntary recommended public offer shall disregard this convening notice as such shareholders have no rights to attend and vote at the Extraordinary General Meeting as their shares are sold.
Agenda
1 Election of new members of the board of directors of Veloxis Pharmaceuticals A/S (current members are expected to resign)
Please see attached document for complete proposals.
For more information, please contact:
Veloxis Pharmaceuticals A/S
Craig A. Collard Ira Duarte
President & CEO CFO
Phone: +1 919 591 3090 Phone: +1 919 591 3090
Email: cac@veloxis.com Email: idu@veloxis.com